Full Article: PDF
Scientific Object Identifier: http://s-o-i.org/1.1/TAS-05-109-14
DOI: https://dx.doi.org/10.15863/TAS.2022.05.109.14
Language: English
Citation: Boronova, Z. S. (2022). Some questions about COVID-19 vaccination (on the example of the Kyrgyz Republic). ISJ Theoretical & Applied Science, 05 (109), 168-170. Soi: http://s-o-i.org/1.1/TAS-05-109-14 Doi: https://dx.doi.org/10.15863/TAS.2022.05.109.14 |
Pages: 168-170
Published: 30.05.2022
Abstract: Coronavirus infection (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus. Most people with COVID-19 have mild or moderate symptoms and recover without specific treatment. However, some people have a severe disease and require medical attention. A COVID-19 vaccine will be a critical tool that, combined with effective testing and existing preventive measures, will help bring the pandemic under control. Experts around the world are working hard to accelerate the development and production of a safe and effective vaccine. UNICEF has committed to deliver COVID-19 vaccines to 92 countries through the COVAX Facility, a unique COVID-19 vaccine manufacturing and centralized procurement initiative. The threat to children posed by COVID-19 is enormous and goes far beyond the immediate physical effects of the disease. Continued or reintroduced lockdown measures seriously affect children's access to basic health care. As a result, declining coverage of routine health services and a looming recession threaten the health and future of an entire generation of children.
Key words: vaccine, human, antigen, microorganism, protection, immunization.
|
